1. Technical Field
The present disclosure relates generally to wound healing, and, in particular, relates to methods and devices for the promotion of wound healing through the application of micro-mechanical forces to localized areas of the wound.
2. Background of Related Art
The application of mechanical stresses to a wound has been found to affect healing of the wound. For example, compressive, tensile and shear forces may be applied to a wound to accelerate the natural healing process. Compressive bandages are commonly used for the treatment of venous leg ulcers, or for patients with interstitial edema, which can impair wound healing. Sub-atmospheric pressure applied to wounds such as a pressure sores, ulcers or burns has been found to promote blood flow to the wound area, stimulate the formation of granulation tissue and encourage the migration of healthy tissue over the wound. These techniques tend to apply forces globally or evenly over large areas of the wound or the patient.
It has also been observed that the application of micro-mechanical forces to localized areas of the wound may cause individual cells to react in a manner beneficial for wound healing. Micro-mechanical forces exerted on individual cells can regulate particular cell functions and may even switch on genes that cause cell proliferation. Experimental data suggests that cells subjected from about 10 percent to about 20 percent strain exhibit proliferation rates favorable for wound healing. Accordingly, devices and methods for the application, concentration or regulation of micro-mechanical forces to localized areas of a wound may promote wound healing.
The present disclosure describes a wound dressing having a micro-architecture to produce appropriate strains in cells to promote the healing of a wound. The apparatus includes a wound cover for defining a reservoir over a wound in which a negative pressure may be maintained by forming a substantially fluid-tight seal around the wound, a vacuum source in fluid communication with the reservoir and suitable for providing an appropriate negative pressure to the reservoir to stimulate healing of the wound, and a porous structure positioned in contact with the wound for delivering micro-mechanical forces to localized areas of the wound. The porous structure comprises a film material having directional apertures formed therein.
The apparatus may include an energy source adapted to deliver energy to the porous structure. The energy source may comprise an ultrasonic horn.
The porous structure may exhibit a male face and an opposite female face, and the porous structure may be positioned such that the male face is in contact with the wound. Alternatively, the porous structure may be positioned such that the female face is in contact with the wound. The directional apertures may be spaced apart by a distance ranging from about 400 microns to about 800 microns, and may be spaced apart by a distance of about 600 microns. The directional apertures may have a diameter ranging from about 50 microns to about 350 microns. The porous structure may exhibit a material thickness ranging from about 25 microns to about 75 microns and a height ranging from about 200 microns to about 300 microns.
According to another aspect of the disclosure, a therapeutic apparatus to promote healing of a wound includes a porous structure in contact with the wound for delivering micro-mechanical forces to localized areas of the wound. The porous structure comprises a film material having directional apertures formed therein. The apparatus also includes an ultrasonic horn adapted to deliver ultrasonic energy to the porous structure.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the present disclosure and, together with the detailed description of the embodiments given below, serve to explain the principles of the disclosure.
Referring initially to
Wound dressing 12 includes a contact layer 18 positioned in direct contact with the bed of wound “w.” Contact layer 18 exhibits a three-dimensional structure that is configured to deliver micro-mechanical forces to localized areas of the wound “w” while permitting the negative pressure applied to the reservoir 14 to penetrate into the wound “w.” Contact layer 18 also permits exudates to be drawn from the wound “w.” An appropriate contact layer 18 is discussed in greater detail below with reference to
Wound filler 20 is positioned in the wound “w” over the contact layer 18 and is intended to allow wound dressing 12 to absorb and capture wound exudates, or to transport wound exudates away from the wound “w” and out of the dressing 12. Wound filler 20 may be cut to a shape that is conformable to the shape of wound “w,” and may be packed up to the level of healthy skin “s,” or alternatively, may overfill the wound “w.” An absorbent material such as gauze, reticulated foam, or alginate fibers may be used for filler 20 to receive or transport any exudate that migrates through contact layer 18. An antimicrobial dressing, commercially available under the trademark KERLIX™ AMD offered by Tyco Healthcare Group LP (d/b/a Covidien), may be suitable for use as filler 20. To prevent adhesion to the wound “w,” the filler 20 may also comprise a material configured such that any stray fibers do not tend to protrude through pores formed in contact layer 18 where they may become engulfed by newly forming granulation tissue. One particular type of material exhibiting this characteristic is formed of continuous filaments comprising either natural or man-made fibers. Continuous filaments include those relatively long strands of a synthetic material such as nylon, rayon, etc., which may offer a smooth continuous outer surface substantially free of the protruding fibrils commonly associated with natural materials such as cotton. The use of continuous filaments of a hydrophobic material such as polyolefin may permit a complete removal of filler 20 when the dressing 12 is changed without re-injuring the wound “w.”
Wound dressing 12 also includes a cover layer 24. Cover layer 24 may be positioned over the wound “w” such that an adhesive on an underside of the cover layer forms a substantially fluid-tight seal with the surrounding skin “s.” Thus, cover layer 24 may act as both a microbial barrier to prevent contaminants from entering the wound “w,” and also a fluid barrier maintaining the integrity of vacuum reservoir 14. Cover layer 24 is preferably formed from a moisture vapor permeable membrane to promote the exchange of oxygen and moisture between the wound “w” and the atmosphere, and is preferably transparent permit a visual assessment of wound conditions without requiring removal of the cover layer 24. A transparent membrane providing a sufficient moisture vapor transmission rate (MVTR) for use as cover layer 24 is sold under the trade name POLYSKIN®II by Tyco Healthcare Group LP (d/b/a Covidien). Alternatively, cover layer 24 may comprise an impermeable membrane or a substantially rigid member.
A vacuum port 30 having a flange 34 may also be included in wound dressing 12 to facilitate connection of the wound dressing 12 to fluid conduit 36. Fluid conduit 36 defines a fluid flow path leading through the apparatus 10. The vacuum port 30 may be configured as a rigid or flexible, low-profile component, and may be adapted to receive a fluid conduit 36 in a releasable and fluid-tight manner. An adhesive on the underside of flange 34 may provide a mechanism for affixing the vacuum port 30 to the dressing 12, or alternatively flange 34 may be positioned within reservoir 14 (not shown) such that an adhesive on an upper side of the flange 34 affixes the vacuum port 30. However it is affixed to the dressing, a hollow interior of the vacuum port 30 provides fluid communication between the fluid conduit 36 and the reservoir 14. Vacuum port 30 may be provided as a pre-affixed component of dressing 12, as a component of fluid conduit 36 or entirely independently. Alternatively, vacuum port 30 may be eliminated from dressing 12 if other provisions are made for providing fluid communication with the fluid conduit 36.
Fluid conduit 36 extends from the vacuum port 30 to provide fluid communication between the reservoir 14 and collection canister 40. Any suitable conduit may be used for fluid conduit 36 including those fabricated from flexible elastomeric or polymeric materials. Fluid conduit 36 may connect to the vacuum port 30, the canister 40, or other apparatus components by conventional air tight means such as friction fit, bayonet coupling, or barbed connectors. The conduit connections may be made permanent, or alternatively a quick-disconnect or other releasable means may be used to provide some adjustment flexibility to the apparatus 10.
Collection canister 40 may comprise any container suitable for containing wound fluids. For example, a rigid bottle may be used as shown or alternatively a flexible polymeric pouch may be appropriate. Collection canister 40 may contain an absorbent material to consolidate or contain the wound drainage or debris. For example, super absorbent polymers (SAP), silica gel, sodium polyacrylate, potassium polyacrylamide or related compounds may be provided within canister 40. At least a portion of canister 40 may be transparent to assist in evaluating the color, quality or quantity of wound exudates. A transparent canister may thus assist in determining the remaining capacity of the canister or when the canister should be replaced.
Leading from collection canister 40 is another section of fluid conduit 36 providing fluid communication with vacuum source 50. Vacuum source 50 generates or otherwise provides a negative pressure to the NWPT apparatus 10. Vacuum source 50 may comprise a peristaltic pump, a diaphragmatic pump or other mechanism that is biocompatible and draws fluids, e.g. atmospheric gasses and wound exudates, from the reservoir 14 appropriate to stimulate healing of the wound “w.” Preferably, the vacuum source 50 is adapted to produce a sub-atmospheric pressure in the reservoir 14 ranging between about 20 mmHg and about 500 mmHg, more preferably, about 75 mmHg to about 125 mmHg, or more preferably, about 40 mmHg to about 80 mmHg.
Apparatus 10 further includes an energy source 60 adapted to supply therapeutic energy to the contact layer 18. The application of energy to the contact layer 18 may concentrate the micro-mechanical stresses that the contact layer 18 applies to wound “w” to further stimulate healing. Energy source 60 comprises an ultrasonic generator that permits various parameters such as output power and frequency to be modulated in order to accommodate particular wound conditions. Energy source 60 is operatively coupled to an appropriate transmitter 62 to transmit energy to the contact layer 18. Here, transmitter 62 comprises an ultrasonic horn, which, in some embodiments, is substantially disconnected from the contact layer 18. The transmitter 62 is thus moveable with respect to wound “w” such that energy may be directed to targeted micro-regions of the wound. For example, the transmitter may be moved around the periphery of wound “w,” which may be more responsive to the application of ultrasonic energy than interior regions of the wound. This arrangement permits energy to be supplied to contact layer 18 through cover layer 24. Alternatively, transmitter 62 of ultrasonic horn 60 and may be placed in contact with cover layer 24 or vacuum port 30 whereby the mechanical energy is transmitted through filler 20 and the exudate to contact layer 18. In some embodiments, transmitter 62 may be directly connected or mounted relative to, or within, cover layer 24 or vacuum port 30 as shown schematically by lines 64, 66, respectively. Ultrasonic horn 60 may be disposable with wound dressing 12. The ultrasonic energy applied will be within therapeutic ranges of frequency and intensity, and will vary with respect to wound type and condition of the wound. A control system 68 containing logic or software may control operation of ultrasonic horn 62 in accordance with predefined treatment modalities as selected by the user.
Ultrasonic energy is a type of mechanical energy that may be effective in transferring motion and mechanical energy directly to the contact layer 18. Alternative types of energy may affect the material properties of the contact layer 18 to cause the contact layer 18 to stretch or deform locally to concentrate the micro-mechanical stresses in the wound “w.” Alternative energy types include light energy, which may be delivered through fiber optics, microwave energy, which may be delivered by an antenna, and magnetic, electrical or heat energy, which may be each be delivered by an appropriately corresponding transmitter.
Referring now to
Each tapered passage 50 includes an aperture or opening “O” located at its apex “A,” while the base “B” of each passage 50 is closed. The apex “A” of each passage 50 is oriented on a male face of the film (as shown in each of
Alternatively, wound contact layer 18 may be oriented such that the male face contacts the wound “w.” In this orientation, the contact layer 18 may be supported only by the film material in the vicinity of the openings “O” such that a smaller surface area of the wound “w” is in contact with the film material than when compared to the opposite orientation. This arrangement permits micro-mechanical forces to be transferred to localized areas of contact with the wound “w” that may be small enough to appropriately stimulate individual cells.
Various features of the contact layer 18 may be designed to precisely control the healing of the wound “w.” For example, by varying the size, shape and location of the openings “O” over the length “l” and breadth “b” of the contact layer 18, different pressures may be experienced by localized regions of the wound “w” as a particular global pressure is applied to the reservoir 14. The size of openings “O” may be selected for particular wound conditions. In some instances, wound healing may be stimulated by a film having openings “O” with a diameter of from about 50 microns to about 350 microns. Also, a spacing “s” of the openings “O” may be selected to control the application of micro-mechanical forces directed at the wound surface. The spacing “s” between adjacent openings “O” of from about 400 microns to about 800 microns may be appropriate. The shape of the openings “O” may also affect healing. The shape of the openings “O” depicted in
Material properties of contact layer 18 such as a film elasticity, material hardness, composition and chemistry may be selected to precisely control aspects of healing. Additionally, agents such as hydrogels and medicaments may be bonded or coated to the contact layer 18 to reduce bioburden in the wound, promote healing and reduce pain associated with changes or removal of the dressing 12. Medicaments include, for example, antimicrobial agents, growth factors, antibiotics, analgesics, and the like. Furthermore, when an analgesic is used, the analgesic could include a mechanism that would allow the release of that agent prior to dressing removal or change.
Although the foregoing disclosure has been described in some detail by way of illustration and example, for purposes of clarity or understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.
This application is a continuation of U.S. application Ser. No. 15/087,909, filed Mar. 31, 2016, which is a continuation application of U.S. application Ser. No. 12/489,883, filed on Jun. 23, 2009, which claims priority to, and the benefit of, U.S. Provisional Application Ser. No. 61/094,517, filed on Sep. 5, 2008 by Heagle, the entire contents of which are being incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
3367332 | Groves | Feb 1968 | A |
3486504 | Austin, Jr. | Dec 1969 | A |
3572340 | Lloyd et al. | Mar 1971 | A |
3712298 | Snowdon et al. | Jan 1973 | A |
3809086 | Schachet et al. | May 1974 | A |
3874387 | Barbieri | Apr 1975 | A |
3929135 | Thompson | Dec 1975 | A |
3972328 | Chen | Aug 1976 | A |
4029598 | Neisius et al. | Jun 1977 | A |
4080970 | Miller | Mar 1978 | A |
4112947 | Nehring | Sep 1978 | A |
4112949 | Rosenthal et al. | Sep 1978 | A |
4136696 | Nehring | Jan 1979 | A |
4266545 | Moss | May 1981 | A |
4382441 | Svedman | May 1983 | A |
4508256 | Radel et al. | Apr 1985 | A |
4524064 | Nambu | Jun 1985 | A |
4710165 | McNeil et al. | Dec 1987 | A |
4728499 | Fehder | Mar 1988 | A |
4743232 | Kruger | May 1988 | A |
4813942 | Alvarez | Mar 1989 | A |
4969880 | Zamierowski | Nov 1990 | A |
4990137 | Graham | Feb 1991 | A |
4997438 | Nipper | Mar 1991 | A |
5056510 | Gilman | Oct 1991 | A |
5071409 | Rosenberg | Dec 1991 | A |
5100395 | Rosenberg | Mar 1992 | A |
5100396 | Zamierowski | Mar 1992 | A |
5106629 | Cartmell et al. | Apr 1992 | A |
5141503 | Sewell, Jr. | Aug 1992 | A |
5149331 | Ferdman et al. | Sep 1992 | A |
5152757 | Eriksson | Oct 1992 | A |
5160322 | Scheremet et al. | Nov 1992 | A |
5176663 | Svedman et al. | Jan 1993 | A |
5178157 | Fanlo | Jan 1993 | A |
5181905 | Flam | Jan 1993 | A |
5195977 | Pollitt | Mar 1993 | A |
5238732 | Krishnan | Aug 1993 | A |
5261893 | Zamierowski | Nov 1993 | A |
5263922 | Sova et al. | Nov 1993 | A |
D364679 | Heaton et al. | Nov 1995 | S |
5484427 | Gibbons | Jan 1996 | A |
5527293 | Zamierowski | Jun 1996 | A |
5536233 | Khouri | Jul 1996 | A |
5549584 | Gross | Aug 1996 | A |
5588958 | Cunningham et al. | Dec 1996 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
5678564 | Lawrence et al. | Oct 1997 | A |
5701917 | Khouri | Dec 1997 | A |
5707499 | Joshi et al. | Jan 1998 | A |
5733305 | Fleischmann | Mar 1998 | A |
5759570 | Arnold | Jun 1998 | A |
5779657 | Daneshvar | Jul 1998 | A |
5840049 | Tumey et al. | Nov 1998 | A |
5852126 | Barnard et al. | Dec 1998 | A |
5911222 | Lawrence et al. | Jun 1999 | A |
5944703 | Dixon et al. | Aug 1999 | A |
6010524 | Fleischmann | Jan 2000 | A |
6071267 | Zamierowski | Jun 2000 | A |
6117111 | Fleischmann | Sep 2000 | A |
6135116 | Vogel et al. | Oct 2000 | A |
D434150 | Turney et al. | Nov 2000 | S |
6142982 | Hunt et al. | Nov 2000 | A |
6174306 | Fleischmann | Jan 2001 | B1 |
6203563 | Fernandez | Mar 2001 | B1 |
6261276 | Reitsma | Jul 2001 | B1 |
6325788 | McKay | Dec 2001 | B1 |
6345623 | Heaton et al. | Feb 2002 | B1 |
6348423 | Griffiths et al. | Feb 2002 | B1 |
6398767 | Fleischmann | Jun 2002 | B1 |
6406447 | Thrash et al. | Jun 2002 | B1 |
6420622 | Johnston et al. | Jul 2002 | B1 |
6458109 | Henley et al. | Oct 2002 | B1 |
6488643 | Tumey et al. | Dec 2002 | B1 |
6500112 | Khouri | Dec 2002 | B1 |
D469175 | Hall et al. | Jan 2003 | S |
D469176 | Hall et al. | Jan 2003 | S |
6520982 | Boynton et al. | Feb 2003 | B1 |
6553998 | Heaton et al. | Apr 2003 | B2 |
D475134 | Randolph | May 2003 | S |
6557704 | Randolph | May 2003 | B1 |
D478659 | Hall et al. | Aug 2003 | S |
6607495 | Skalak et al. | Aug 2003 | B1 |
6626891 | Ohmstede | Sep 2003 | B2 |
6648862 | Watson | Nov 2003 | B2 |
6685681 | Lockwood et al. | Feb 2004 | B2 |
6689986 | Patel et al. | Feb 2004 | B2 |
6695823 | Lina et al. | Feb 2004 | B1 |
6695824 | Howard et al. | Feb 2004 | B2 |
D488558 | Hall | Apr 2004 | S |
6752794 | Lockwood et al. | Jun 2004 | B2 |
6755807 | Risk, Jr. et al. | Jun 2004 | B2 |
6764462 | Risk, Jr. et al. | Jul 2004 | B2 |
6767334 | Randolph | Jul 2004 | B1 |
6800074 | Henley et al. | Oct 2004 | B2 |
6814079 | Heaton et al. | Nov 2004 | B2 |
6824533 | Risk, Jr. et al. | Nov 2004 | B2 |
6855135 | Lockwood et al. | Feb 2005 | B2 |
6855860 | Ruszczak et al. | Feb 2005 | B2 |
6856821 | Johnson | Feb 2005 | B2 |
6887228 | McKay | May 2005 | B2 |
6887263 | Bleam et al. | May 2005 | B2 |
6936037 | Bubb et al. | Aug 2005 | B2 |
6942633 | Odland | Sep 2005 | B2 |
6942634 | Odland | Sep 2005 | B2 |
6951553 | Bubb et al. | Oct 2005 | B2 |
6960181 | Stevens | Nov 2005 | B2 |
6979324 | Bybordi et al. | Dec 2005 | B2 |
6994702 | Johnson | Feb 2006 | B1 |
7004915 | Boynton et al. | Feb 2006 | B2 |
7022113 | Lockwood et al. | Apr 2006 | B2 |
7037254 | O'Connor et al. | May 2006 | B2 |
7052167 | Vanderschuit | May 2006 | B2 |
7070584 | Johnson et al. | Jul 2006 | B2 |
7077832 | Fleischmann | Jul 2006 | B2 |
7108683 | Zamierowski | Sep 2006 | B2 |
7117869 | Heaton et al. | Oct 2006 | B2 |
7128719 | Rosenberg | Oct 2006 | B2 |
7128735 | Weston | Oct 2006 | B2 |
7144390 | Hanningan et al. | Dec 2006 | B1 |
7169151 | Lytinas | Jan 2007 | B1 |
7182758 | McCraw | Feb 2007 | B2 |
7195624 | Lockwood et al. | Mar 2007 | B2 |
7198046 | Argenta et al. | Apr 2007 | B1 |
7214202 | Vogel et al. | May 2007 | B1 |
7216651 | Argenta et al. | May 2007 | B2 |
D544092 | Lewis | Jun 2007 | S |
7273054 | Heaton et al. | Sep 2007 | B2 |
7276051 | Henley et al. | Oct 2007 | B1 |
7279612 | Heaton et al. | Oct 2007 | B1 |
7316672 | Hunt et al. | Jan 2008 | B1 |
D565177 | Locke et al. | Mar 2008 | S |
7338482 | Lockwood et al. | Mar 2008 | B2 |
7351250 | Zamierowski | Apr 2008 | B2 |
7361184 | Joshi | Apr 2008 | B2 |
7381211 | Zamierowski | Jun 2008 | B2 |
7381859 | Hunt et al. | Jun 2008 | B2 |
7381860 | Gudnason et al. | Jun 2008 | B2 |
7396345 | Knighton et al. | Jul 2008 | B2 |
7410495 | Zamierowski | Aug 2008 | B2 |
7413570 | Zamierowski | Aug 2008 | B2 |
7413571 | Zamierowski | Aug 2008 | B2 |
7422576 | Boynton et al. | Sep 2008 | B2 |
7494482 | Orgill et al. | Feb 2009 | B2 |
7534927 | Lockwood et al. | May 2009 | B2 |
7569742 | Haggstrom et al. | Aug 2009 | B2 |
7605298 | Bechert et al. | Oct 2009 | B2 |
7612247 | Oyaski | Nov 2009 | B2 |
7615036 | Joshi et al. | Nov 2009 | B2 |
7622629 | Aail | Nov 2009 | B2 |
7625362 | Boehringer et al. | Dec 2009 | B2 |
7670323 | Hunt et al. | Mar 2010 | B2 |
7699823 | Haggstrom et al. | Apr 2010 | B2 |
7700819 | Ambrosio et al. | Apr 2010 | B2 |
7708724 | Weston | May 2010 | B2 |
7722582 | Lina et al. | May 2010 | B2 |
7723560 | Lockwood et al. | May 2010 | B2 |
7731702 | Bybordi et al. | Jun 2010 | B2 |
7749531 | Booher | Jul 2010 | B2 |
7759537 | Bishop et al. | Jul 2010 | B2 |
7759539 | Shaw et al. | Jul 2010 | B2 |
7775998 | Riesinger | Aug 2010 | B2 |
7776028 | Miller et al. | Aug 2010 | B2 |
7779625 | Joshi et al. | Aug 2010 | B2 |
7811269 | Boynton et al. | Oct 2010 | B2 |
7838717 | Haggstrom et al. | Nov 2010 | B2 |
7846141 | Weston | Dec 2010 | B2 |
7896856 | Petrosenko et al. | Mar 2011 | B2 |
7909805 | Weston | Mar 2011 | B2 |
7910791 | Coffey | Mar 2011 | B2 |
7922703 | Riesinger | Apr 2011 | B2 |
7927318 | Risk, Jr. et al. | Apr 2011 | B2 |
7959624 | Riesinger | Jun 2011 | B2 |
7964766 | Blott et al. | Jun 2011 | B2 |
7976519 | Bubb et al. | Jul 2011 | B2 |
8007257 | Heaton et al. | Aug 2011 | B2 |
8034037 | Adams et al. | Oct 2011 | B2 |
8062272 | Weston | Nov 2011 | B2 |
8062331 | Zamierowski | Nov 2011 | B2 |
8080702 | Blott et al. | Dec 2011 | B2 |
8118794 | Weston | Feb 2012 | B2 |
8152785 | Vitaris | Apr 2012 | B2 |
8162907 | Heagle | Apr 2012 | B2 |
8168848 | Lockwood et al. | May 2012 | B2 |
8207392 | Haggstrom et al. | Jun 2012 | B2 |
8235972 | Adahan | Aug 2012 | B2 |
8241261 | Randolph et al. | Aug 2012 | B2 |
8282611 | Weston | Oct 2012 | B2 |
8303552 | Weston | Nov 2012 | B2 |
8372049 | Jaeb et al. | Feb 2013 | B2 |
8372050 | Jaeb et al. | Feb 2013 | B2 |
8425478 | Olson | Apr 2013 | B2 |
8444612 | Patel et al. | May 2013 | B2 |
8460255 | Joshi et al. | Jun 2013 | B2 |
8513481 | Gergeley et al. | Aug 2013 | B2 |
8535283 | Heaton et al. | Sep 2013 | B2 |
8545466 | Andresen et al. | Oct 2013 | B2 |
8556871 | Mormino et al. | Oct 2013 | B2 |
8568386 | Malhi | Oct 2013 | B2 |
8628505 | Weston | Jan 2014 | B2 |
8641691 | Fink et al. | Feb 2014 | B2 |
8663198 | Buan et al. | Mar 2014 | B2 |
8679079 | Heaton et al. | Mar 2014 | B2 |
8715256 | Greener | May 2014 | B2 |
8764732 | Hartwell | Jul 2014 | B2 |
8795243 | Weston | Aug 2014 | B2 |
8808274 | Hartwell | Aug 2014 | B2 |
8829263 | Haggstrom et al. | Sep 2014 | B2 |
8834451 | Blott et al. | Sep 2014 | B2 |
8834452 | Hudspeth et al. | Sep 2014 | B2 |
8864748 | Coulthard et al. | Oct 2014 | B2 |
8956336 | Haggstrom et al. | Feb 2015 | B2 |
9012714 | Fleischmann | Apr 2015 | B2 |
9168330 | Joshi et al. | Oct 2015 | B2 |
9199012 | Vitaris et al. | Dec 2015 | B2 |
9220822 | Hartwell | Dec 2015 | B2 |
9302033 | Riesinger | Apr 2016 | B2 |
9375353 | Vitaris et al. | Jun 2016 | B2 |
9375521 | Hudspeth et al. | Jun 2016 | B2 |
9381283 | Adams et al. | Jul 2016 | B2 |
9414968 | Heagle | Aug 2016 | B2 |
9421309 | Robinson et al. | Aug 2016 | B2 |
9446178 | Blott et al. | Sep 2016 | B2 |
9452248 | Blott et al. | Sep 2016 | B2 |
9629986 | Patel et al. | Apr 2017 | B2 |
9669138 | Joshi et al. | Jun 2017 | B2 |
9795725 | Joshi et al. | Oct 2017 | B2 |
9844473 | Blott et al. | Dec 2017 | B2 |
9956121 | Hartwell | May 2018 | B2 |
9962474 | Greener | May 2018 | B2 |
10016309 | Hartwell | Jul 2018 | B2 |
20010031943 | Urie | Oct 2001 | A1 |
20010043943 | Coffey | Nov 2001 | A1 |
20020016577 | Ohmstede | Feb 2002 | A1 |
20020143286 | Tumey | Oct 2002 | A1 |
20020151836 | Burden | Oct 2002 | A1 |
20020161346 | Lockwood et al. | Oct 2002 | A1 |
20030078532 | Ruszczak et al. | Apr 2003 | A1 |
20030093041 | Risk, Jr. et al. | May 2003 | A1 |
20030212357 | Pace | Nov 2003 | A1 |
20030212359 | Butler | Nov 2003 | A1 |
20030219469 | Johnson et al. | Nov 2003 | A1 |
20040039415 | Zamierowski | Feb 2004 | A1 |
20040057855 | Gerlach et al. | Mar 2004 | A1 |
20040064111 | Lockwood et al. | Apr 2004 | A1 |
20040064132 | Boehringer et al. | Apr 2004 | A1 |
20040093026 | Weidenhagen et al. | May 2004 | A1 |
20040122434 | Argenta et al. | Jun 2004 | A1 |
20040167482 | Watson | Aug 2004 | A1 |
20040193218 | Butler | Sep 2004 | A1 |
20040241213 | Bray | Dec 2004 | A1 |
20040249353 | Risk, Jr. et al. | Dec 2004 | A1 |
20040260230 | Randolph | Dec 2004 | A1 |
20050020955 | Sanders et al. | Jan 2005 | A1 |
20050085795 | Lockwood et al. | Apr 2005 | A1 |
20050090787 | Risk, Jr. et al. | Apr 2005 | A1 |
20050131327 | Lockwood et al. | Jun 2005 | A1 |
20050137539 | Biggie et al. | Jun 2005 | A1 |
20050147562 | Hunter et al. | Jul 2005 | A1 |
20050177190 | Zamierowski | Aug 2005 | A1 |
20050182445 | Zamierowski | Aug 2005 | A1 |
20060009744 | Erdman et al. | Jan 2006 | A1 |
20060029650 | Coffey | Feb 2006 | A1 |
20060039742 | Cable, Jr. et al. | Feb 2006 | A1 |
20060100586 | Karpowicz et al. | May 2006 | A1 |
20060149170 | Boynton et al. | Jul 2006 | A1 |
20070005028 | Risk, Jr. et al. | Jan 2007 | A1 |
20070014837 | Johnson et al. | Jan 2007 | A1 |
20070016152 | Karpowicz | Jan 2007 | A1 |
20070021697 | Ginther et al. | Jan 2007 | A1 |
20070027414 | Hoffman et al. | Feb 2007 | A1 |
20070032754 | Walsh | Feb 2007 | A1 |
20070032755 | Walsh | Feb 2007 | A1 |
20070032778 | Heaton et al. | Feb 2007 | A1 |
20070040454 | Freudenberger et al. | Feb 2007 | A1 |
20070055209 | Patel et al. | Mar 2007 | A1 |
20070066925 | Gudnason et al. | Mar 2007 | A1 |
20070178145 | Chou et al. | Aug 2007 | A1 |
20070179460 | Adahan | Aug 2007 | A1 |
20070225663 | Watt et al. | Sep 2007 | A1 |
20070299369 | Babaev | Dec 2007 | A1 |
20080031748 | Ihle et al. | Feb 2008 | A1 |
20080071235 | Locke et al. | Mar 2008 | A1 |
20080132821 | Propp et al. | Jun 2008 | A1 |
20080200857 | Lawhorn | Aug 2008 | A1 |
20080200905 | Heaton et al. | Aug 2008 | A1 |
20080200906 | Sanders et al. | Aug 2008 | A1 |
20080208147 | Argenta et al. | Aug 2008 | A1 |
20080234641 | Locke et al. | Sep 2008 | A1 |
20080306456 | Riesinger | Dec 2008 | A1 |
20090125004 | Shen et al. | May 2009 | A1 |
20090157024 | Song | Jun 2009 | A1 |
20090234306 | Vitaris | Sep 2009 | A1 |
20090275922 | Coulthard et al. | Nov 2009 | A1 |
20090299251 | Buan | Dec 2009 | A1 |
20090299306 | Buan | Dec 2009 | A1 |
20100125258 | Coulthard et al. | May 2010 | A1 |
20100259406 | Caso et al. | Oct 2010 | A1 |
20100318052 | Ha et al. | Dec 2010 | A1 |
20110118683 | Weston | May 2011 | A1 |
20110295220 | Heaton et al. | Dec 2011 | A1 |
20130090615 | Jaeb et al. | Apr 2013 | A1 |
20130102979 | Coulthard et al. | Apr 2013 | A1 |
20130138054 | Fleischmann | May 2013 | A1 |
20130150814 | Buan | Jun 2013 | A1 |
20130165878 | Heagle | Jun 2013 | A1 |
20130274688 | Weston | Oct 2013 | A1 |
20130338614 | Heaton et al. | Dec 2013 | A1 |
20140155849 | Heaton et al. | Jun 2014 | A1 |
20150065965 | Haggstrom | Mar 2015 | A1 |
20160256673 | Heagle | Sep 2016 | A1 |
20160317357 | Vitaris et al. | Nov 2016 | A1 |
20170128642 | Buan | May 2017 | A1 |
20170181896 | Hartwell | Jun 2017 | A1 |
20170181897 | Hartwell | Jun 2017 | A1 |
Number | Date | Country |
---|---|---|
34 43 101 | May 1986 | DE |
41 11 122 | Apr 1993 | DE |
295 04 378 | Oct 1995 | DE |
20 2004 017 052 | Jun 2005 | DE |
0 020 662 | Jul 1984 | EP |
0 340 018 | Nov 1989 | EP |
0 358 302 | Mar 1990 | EP |
0 853 950 | Jul 1998 | EP |
1 088 569 | Apr 2001 | EP |
1 219 311 | Jul 2002 | EP |
1 476 217 | Nov 2004 | EP |
1 955 887 | Aug 2008 | EP |
2 079 507 | Jul 2009 | EP |
2 462 908 | Jun 2012 | EP |
2 687 245 | Jan 2014 | EP |
2 711 034 | Mar 2014 | EP |
2 305 325 | Apr 2014 | EP |
2 345 437 | Apr 2014 | EP |
1 163 907 | Oct 1958 | FR |
1255395 | Dec 1971 | GB |
1 549 756 | Aug 1979 | GB |
2 195 255 | Apr 1988 | GB |
2 235 877 | Mar 1991 | GB |
2 307 180 | Nov 1996 | GB |
2 329 127 | Mar 1999 | GB |
2 336 546 | Oct 1999 | GB |
2 344 531 | Jun 2000 | GB |
2 415 908 | Jan 2006 | GB |
1762940 | Jan 1989 | SU |
WO 198001139 | Jun 1980 | WO |
WO 198002182 | Oct 1980 | WO |
WO 198300742 | Mar 1983 | WO |
WO 198401904 | May 1984 | WO |
WO 198905133 | Jun 1989 | WO |
WO 199011795 | Oct 1990 | WO |
WO 199219313 | Nov 1992 | WO |
WO 1993009727 | May 1993 | WO |
WO 199420041 | Sep 1994 | WO |
WO 199605873 | Feb 1996 | WO |
WO 200021586 | Apr 2000 | WO |
WO 2003005943 | Jan 2003 | WO |
WO 2003018098 | Mar 2003 | WO |
WO 2003030966 | Apr 2003 | WO |
WO 2003045492 | Jun 2003 | WO |
WO 2003057070 | Jul 2003 | WO |
WO 2003057307 | Jul 2003 | WO |
WO 2003086232 | Oct 2003 | WO |
WO 2003092620 | Nov 2003 | WO |
WO 2003101508 | Dec 2003 | WO |
WO 2004018020 | Mar 2004 | WO |
WO 2004077387 | Sep 2004 | WO |
WO 2005009488 | Feb 2005 | WO |
WO 2005025447 | Mar 2005 | WO |
WO 2005123170 | Dec 2005 | WO |
WO 2006052839 | May 2006 | WO |
WO 2006105892 | Oct 2006 | WO |
WO 2008039223 | Apr 2008 | WO |
WO 2009066105 | May 2009 | WO |
WO 2009124100 | Oct 2009 | WO |
WO 2009158128 | Dec 2009 | WO |
WO 2010142959 | Dec 2010 | WO |
Entry |
---|
US 6,216,701 B1, 04/2001, Heaton et al. (withdrawn) |
US 7,186,244 B1, 03/2007, Hunt et al. (withdrawn) |
International Search Report, re PCT Application No. PCT/US09/48351, dated Oct. 28, 2009. |
Aubrey, D.A., et al., Treatment of the Perineal Wound after Proctectomy by Intermittent Irrigation, Arch. Surg., Oct. 1984, 119, 1141-1144. |
Bagautdinov, N.A., “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of Soft Tissues,” in current Problems in Modern Clinical Surgery: Interdepartmental Collection, edited by V. Ye. Volkov et al. (Chuvashia State University, Cheboksary, USSR 1986) pp. 94-96 (with English translation). |
Arnljots, et al., “Irrigation Treatment in Split-thickness Skin Grafting of Intractable Leg Ulcers,” Scand J Plast Reconstr Surg 19: 211-213,1985. |
Chardack, et al., “Experimental studies on Synthetic Substitutes for Skin and Their Use in the Treatment of Burns,” vol. 155, No. 1 (128-136), 1961. |
Chariker, M.E., et al, “Effective Management of Incisional and Cutaneous Fistulae with Closed Suction Wound Drainage,” Contemporary Surgery. Jun. 1989, pp. 59-63, vol. 34. |
Fleischmann, “Vacuum Sealing for Treatment of Problematical Wounds”, University Surgical Clinic and Polyclinic—Accident Surgery Department, WundForum Spezial-IHW 94. |
Fleischmann et al., “Vacuum Sealing: Indication, Technique and Results”, Emr J Orthop Surg Tramatol (1995) 5:37-40. |
Garcia-Rinaldi, R., et al., Improving the Efficiency of Wound Drainage Catheters, Amer. Journ. of Surg., Sep. 1975, 130, 372-373. |
Gorica Zivadinovic, et al., “Vacuum Therapy in the Treatment of Peripheral Blood Vessels,” Conference Papers of the 5th Timok Medical Days, Majdanpek, 1986 (161-164). |
Health Technology, Literature R., “Vacuum Assisted Closure Therapy for Wound Care”, Health Technology Literature Review (Dec. 2004), 3-59. |
Jeter, Katherine F., et al., “Managing Draining Wounds and Fistulae: New and Established Methods”, Chronic Wound Care, 1990, pp. 240-246. |
Kostiuchenok, B. M., et al., “The Vacuum Effect in the Surgical Treatment of Purulent Wounds”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California (2004), 3-4. |
Kostiuchenok, et al., “The Vacuum Effect in the Surgical Treatment of Purulent Wounds,” Russian Journal: Vestnik Khirurgii, Sep. 1986 (18-21). |
Meyer, MD., et al., “In Surgery, Medicine and the Specialties a Manual of its Practical Application”, Bier's Hyperemic Treatment, Second Revised Edition, W.B. Saunders Company, 1909. |
Morykwas, Michael J., et al., “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies and Basic Foundation”, Ann Plast Surg 1997;38:553-562 (Dec. 10, 1996). |
Mulder, GD, et al., “Clinicians' Pocket Guide to Chronic Wound Repair,” Wound Healing Publications Second Edition, 1991. |
Ryosuke Fujimoro, MD., et al., “Sponge Fixation Method for Treatment of Early Scars,” From the Department of Dermatology in the Faculty Medicine, Kyoto University, vol. 42, No. 4, Oct. 1968 (322-326). |
Sandén, Göran MD., et al., “Staphylococcal Wound Infection in the Pig: Part II. Innoculation, Quantification of Bacteria, and Reproducibility,” Annals of Plastic Surgery, vol. 23, No. 3, Sep. 1989, (219-223). |
Stewart, Joanne, Ph.D., World Wide Wounds—Next generation of products for wound management—2002 (13 pages). |
Stoll, “Energetic Remedies—Cupping: Healing Within a Vacuum,” https:l/www.suite101.com/article.cfm/ energetic)remedies/74531, Apr. 13, 2005. |
Svedman, “A Dressing Allowing Continuous Treatment of a Biosurface” IRCS Medical Science: Biomedical Technology; Clinical Medicine; Surgery and Transplantation, 7, 221 (1979). |
Svedman, “A Dressing System Providing Fluid Supplu and Suction Drainage Used for Continuous or Intermittent Irrigation,” Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986 (125-133). |
Svedman, P., “Irrigation Treatment of Leg Ulcers,” The Lancet, Sep. 3, 1983 (532-534). |
Svedman, et al., “Staphylococcal Wound Infection in the Pig: Part I. Course,” Annals of Plastic Surgery, vol. 23, No. 3, Sep. 1989 (212-218). |
Teder et al., “Continuous Wound Irrigation in the Pig,” Journal of Investigative Surgery, 1990, vol. 3, pp. 399-407. |
Tribble, David E. M.D., An Improved Sump Drain-Irrigation Device of Simple Construction, Archives of Surgery New York, pp. 511-513, 1972 vol. 105. |
Usupov, et al., “Archive Wound Drainage,” Russian Journal: Vestnik Khirugii, Apr. 1987 (42-45). |
Wu, W.S., et al., Vacuum therapy as an intermediate phase in wound closure: a clinical experience, Eur J. Past Surg (2000) 23: 174-177. |
Yu A. Davydov, et al., “Bacteriological and Cytological Assessment of Vacuum Therapy of Purulent Wounds”, Vestnik Khirurgii, Oct. 1988 (48-52). |
Yu A. Davydov, et al., “Concepts for Clinical Biological Management of the Wound Process in the Treatment of Purulent Wounds Using Vacuum Therapy,” Vestnik Khirugii, Feb. 1991, 132-135). |
Yu A. Davydov, et al., “Vacuum Therapy in the Treatment of Purulent Lactation Mastitis,” Russian Journal: Vesnik Khirurgii, Sep. 1986 (66-70). |
Yu A. Davydov, et al., “Vacuum Therapy in treatment of Acute Purulent Diseases of Soft Tissues and Purulent Wounds,” Vestnik Khirurgii, (Surgeon's Herald), Medicine Publishers, 1986. |
International Search Report and Written Opinion, re PCT Application No. PCT/US2009/48351, dated Nov. 13, 2009. |
International Preliminary Report, re PCT Application No. PCT/US2009/48351, dated Mar. 17, 2011. |
“Technology Watch”, May 1989, in 1 page. |
Aubrey, D.A., et al., Treatment of the Perineal Wound after Proctectomy by Intermittent Irrigation, Arch. Surg., Oct. 1984, 119, 1141-1144, in 4 pages. |
Bier, A., Hyperemia as a Therapeutic Agent, Ed. Dr. Gustavus M. Blech, A. Robertson & Co., Chicago 1905. |
Bucalo et al. “Inhibition of Cell Proliferation by Chronic Wound Fluid.” Wound Repair and Regeneration. Miami, 1993. pp. 181-186. |
Edlich, R.F., et al., “Evaluation of a New, Improved Surgical Drainage System,” The American Journal of Surgery, vol. 149, pp. 295-298, Feb. 1985. |
Garcia-Rinaldi, R., et al., Improving the Efficiency of Wound Drainage Catheters, Amer. Journ. of Surg., Sep. 1975, 130, 372-373, in 2 pages. |
Health Technology Literature Review, “Vacuum Assisted Closure Therapy for Wound Care”, The Medical Advisory Secretariat, Dec. 2004, pp. 3-57, in 57 pages. |
Hersle, K. et al., “Uses of Dextranomer Absorbent Pads After Cryosurgery of Cutaneous Malignancies”, The Journal of Dermatologic Surgery and Oncology, vol. 8, Jan. 1982, in 4 pages. |
Kendall ULTEC Hydrocolloid Dressing (4″×4″), product ordering page, web page downloaded Jul. 13, 2014, in 1 page. |
McLaughlan, James, Sterile Microenvironment for Postoperative Wound Care, The Lancet, pp. 503-504, Sep. 2, 1978. |
Advantec MFS, Inc., “Membrane Filters” (catalog), accessed Jan. 29, 2016 (publication date unknown, but believed to be copyright 2001-2011), in 17 pages. URL: http://www.advantecmfs.com/catalog/filt/membrane.pdf#page=11. |
Morykwas, Michael J., et al., “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies and Basic Foundation”, Ann Plast Surg 1997; 38:553-562 (Dec. 10, 1996), in 10 pages. |
Protz, K., “Moderne Wundauflagen unterstutzen Heilungsprozess”, Wundversorgung: Indikation and Anwendung, Geriatrie Journal, Apr. 2005, pp. 3333-3339, with translation, in 17 pages. |
Renasys EZ System for Negative Wound Therapy, Smith & Nephew announcement, dated Feb. 24, 2009, in 3 pages. |
Sames, C.P., Sealing of Wounds with Vacuum Drainage, Br. Med. Journ., Nov. 5, 1977, p. 1223, Correspondence. |
Smith & Nephew, “PICO Single Use Negative Pressure Wound Therapy System”, spiral booklet, Mar. 2011, in 7 pages. |
Stewart, Joanne, Ph.D., World Wide Wounds—Next generation of products for wound management—2002, in 13 pages. |
Tribble, D. M.D., “An Improved Sump Drain-Irrigation Device of Simple Construction”, Archives of Surgery New York, pp. 511-513, 1972 vol. 105, in 4 pages. |
Wu, W.S., et al. Vacuum therapy as an intermediate phase in wound closure: a clinical experience, Eur J Past Surg (2000) 23: 174-177, in 6 pages. |
Number | Date | Country | |
---|---|---|---|
20170252545 A1 | Sep 2017 | US |
Number | Date | Country | |
---|---|---|---|
61094517 | Sep 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15087909 | Mar 2016 | US |
Child | 15436469 | US | |
Parent | 12489883 | Jun 2009 | US |
Child | 15087909 | US |